• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Venture capital deals

By
Dan Primack
Dan Primack
Down Arrow Button Icon
By
Dan Primack
Dan Primack
Down Arrow Button Icon
November 29, 2012, 3:21 PM ET

CardiAQ Technologies Inc., an Irvine, Calif.-based developer of devices for percutaneous mitral heart valve replacement, has raised $37.3 million in second-round funding. OrbiMed Advisors led the round, and was joined by Versant Ventures, Advent Life Sciences and return backers like Broadview Advisors.www.cardiaq.com

Acquia, a Burlington, Mass.-based enterprise guide to Drupal, has raised $30 million in new VC funding.Investor Growth Capital led the round, and was joined by Goldman Sachs, Accolade Partners and return backers North Bridge Venture Partners, Sigma Partners and Tenaya Capital. The company now has raised a total of $68.5 million. www.acquia.com

MyHeritage, an Israel-based genealogy site, has raised $25 million in new VC funding. Bessemer Venture Partners led the round, and was joined by return backers Accel Partners and Index Ventures. In related news, MyHeritage has acquired California-based rival Geni.com, which had raised over $16 million from firms like Charles River Ventures and Founders Fund. No financial terms of the acquisition were disclosed. www.myheritage.com

Rib-X Pharmaceuticals Inc., a New Haven, Conn.-based developer of antibiotics, closed on an $18.7 million first tranche of a $67.5 million Series 2 preferred stock financing. A second tranche is expected to close by year-end. Vatera Healthcare Partners led the round, and was joined by return backers Warburg Pincus, ABS Ventures and Vox Equity Partners. Rib-X postponed a planned IPO back in May. www.rib-x.com

NoMoRerack, a New York-based deep-discount apparel retailer, has raised $12 million in VC funding, according to a regulatory filing. Backers include Oak Investment Partners. www.nomorerack.com

NanoBio Corp.
, an Ann Arbor, Mich.-based developer of dermatological products, anti-infective treatments and intranasal & intramuscular vaccines, has raised $11 million in Series C funding. Return backers include Perseus and Venture Investors LLC. www.nanobio.com

AgilOne
, a Mountain View, Calif.-based predictive marketing intelligence company, has raised $10 million in Series B funding. Mayfield Fund led the round, and was joined by return backer Sequoia Capital. www.agilone.com

Ginger.io
, a San Francisco-based behavioral health analytics startup, has raised $6.5 million in Series A funding. Khosla Ventures led the round, and was joined by return backers True Ventures and Romulus Capital. www.ginger.io

Indisys, a Spanish maker of natural language virtual telephone assistants, has raised $5 million in new VC funding. Intel Capital led the round, and was joined by Inveready Technology Investment Group.www.indisys.es

Macheen Inc., an Austin, Texas-based cloud service provider for connected devices, has raised an undisclosed amount of strategic funding from Qualcomm Inc. In September, the company announced a $10 million Series C raise from GemVentures, North Bridge Venture Partners and DFJ Mercury.www.macheen.com

Sign up for Dan’s daily email newsletter on deals and deal-makers: GetTermSheet.com

About the Author
By Dan Primack
See full bioRight Arrow Button Icon

Latest in

CryptoBinance
Binance has been proudly nomadic for years. A new announcement suggests it’s finally chosen a headquarters
By Ben WeissDecember 7, 2025
3 hours ago
Big TechStreaming
Trump warns Netflix-Warner deal may pose antitrust ‘problem’
By Hadriana Lowenkron, Se Young Lee and BloombergDecember 7, 2025
6 hours ago
Big TechOpenAI
OpenAI goes from stock market savior to burden as AI risks mount
By Ryan Vlastelica and BloombergDecember 7, 2025
7 hours ago
InvestingStock
What bubble? Asset managers in risk-on mode stick with stocks
By Julien Ponthus, Natalia Kniazhevich, Abhishek Vishnoi and BloombergDecember 7, 2025
7 hours ago
EconomyTariffs and trade
Macron warns EU may hit China with tariffs over trade surplus
By James Regan and BloombergDecember 7, 2025
7 hours ago
EconomyTariffs and trade
U.S. trade chief says China has complied with terms of trade deals
By Hadriana Lowenkron and BloombergDecember 7, 2025
7 hours ago

Most Popular

placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
1 day ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
1 day ago
placeholder alt text
Big Tech
Mark Zuckerberg rebranded Facebook for the metaverse. Four years and $70 billion in losses later, he’s moving on
By Eva RoytburgDecember 5, 2025
3 days ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
11 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.